Skip to main content
. 2018 Oct 30;49(3):864–874. doi: 10.1002/jmri.26285

Table 4.

Histopathological Subtypes of the Patient Population

Histology Subtype n %
Malignant (n = 136) Invasive ductal carcinoma 119 56.6
Invasive lobular carcinoma 10 4.8
Ductal carcinoma in situ 4 1.9
Mucinous 1 0.5
Myelosarcoma Metastasis 1 1 0.5 0.5
Benign (n = 74) High risk lesions 9 4.3
Fibroadenoma / fibroadenomatoid hyperplasia 47 22.4
Fibrocystic changes without atypiab 12 5.7
Miscellaneous (eg, fat necrosis, cyst with inflammation) 5 2.4
Total 210 100